Bibliographie
D. Alagille, « Hémophilies classiques, hémophilies latentes », in Le Concours méd., t. XCII, no 8, 1970
R. Biggs & R. G. Mac-farlane, Human Blood Coagulation and Its Disorders, Oxford, 3e éd. 1962
R. de Biasi, A. Rocino, E. Miraglia, L. Mastrullo & A. A. Quirino, « The Impact of a Very High Purity Factor VIII Concentrate on the Immune System of Human Immunodeficiency Virus-Infected Hemophiliacs : a Randomized, Prospective, Two-year Comparison with an Intermediate Purity Concentrate », in Blood, vol. LXXVIII, 1991
A. L. Bloom, « Progress in the Clinical Management of Haemophilia », in Thromb. Haemost., vol. LXVI, no 1, 1991
R. Bourdon, J. Bernard, J. Caen, M. Bard & C. Patrux, « Données évolutives des lésions ostéo-articulaires radiologiques de l'hémophilie », in Semaine des hôpitaux, t. XXXIX, 1963
K. M. Brinkhous, The Hemophilias, Chapel Hill, 1964
W. Bulloch & P. Fildes, Haemophila : the Treasury of Human Inheritance, part. V et VI, sect. XIV a, Londres, 1911
K. H. Choo, K. G. Gould, D. J. Rees & G. G. Brownlee, « Molecular Cloning of the Gene for Human Anti-Haemophilic Factor IX », in Nature, vol. CCXCIX, 1982
J. Gitschier, W. I. Wood, T. M. Goralka et al., « Characterization of the Human Factor VIII Gene », in Nature, vol. CCCXII, 1984
R. M. Hardisty & G. I. C. Ingram, Blooding Disorders. Investigation and Management, Oxford, 1965
M. W. Hilgartner, « The Need for Recombinant Factor VIII : Historical Background and Rationale », in Semin. Hematol., vol. XXVIII, no 2, 1991
B. Horowitz, M. E. Wiebe, A. Lippin, J. Vandersande & M. H. Stryker, « Inactivation of Viruses in Labile Blood Derivatives. I. Disruption of Lipid-enveloped Virus by Tri (n-butyl) Phosphate Detergent Combinations in Transfusion », in Transfusion, vol. XXV, 1985
C. K. Kasper, « Treatment of Factor VIII Inhibitors », in Coller BS, éd. Progress in hemostasis and thrombosis, vol. IX, W. B. Saunders, Philadelphie, 1989
C. K. Kasper, J. M. Lusher & The Transfusion Practices Committee, « Recent Evolution of Clotting Factor Concentrates for Hemophilia A and B », in Transfusion, vol. XXXIII, no 5, 1993
J. M. Lusher, S. Arkin, C. F. Abildgaard, R. S. Schwartz & The Kogenate Previously Untreated Patient Study Group, « Recombinant Factor VIII for the Treatment of Previously Untreated Patients with Hemophilia A : Safety, Efficacy and Development of Inhibitors », in N. Engl. J. Med., vol. CCCXXVIII, no 7, 1993
J. C. Otto, « An Account of an Haemorragic Disposition Existing in Certain Families », in Med. Repository, vol. VI, 1803
A. J. Patek & F. H. L. Taylor, « Haemophilia II. Some Properties of a Substance Obtained from Normal Human Plasma Effective in Accelerating the Coagulation of Haemophilic Blood », in J. clin. Invest., vol. XVI, 1937
A. Pavlovsky, « Contribution to the Pathogenesis of Haemophilia », in Blood, vol. II, 1947
Plasma Fractions for the Treatment of Haemophilia, Stuttgart-New York, 1969
F. Rosner, « Haemophilia in the Talmud and Rabbinic Writings », in Ann. int. Med., vol. LXX, 1969
J. P. Soulier & F. Josso, « Données nouvelles sur l'hémophilie », in Bibliotheca haematologica, t. XXVI, 1966.
Retour en haut
… pour nos abonnés, l'article se prolonge sur 6 pages…
